Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 18, 2017

Primary Completion Date

October 24, 2017

Study Completion Date

October 24, 2017

Conditions

Bioequivalence

Interventions

DRUG

Rinsulin® mix 30/70

one subcutaneous injection at a dose of 0.4 IU/kg

DRUG

Humulin® M3

one subcutaneous injection at a dose of 0.4 IU/kg

Trial Locations (3)

"National Medical Research Center of Endocrinology of the Ministry of Health of the Russian Federation", Moscow

"National Medical Research Center in name of V.A. Almazov of the Ministry of Health of the Russian Federation", Saint Petersburg

"LLC BioEk, Russian Federation", Saint Petersburg